目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. DNA SYNTHESIS MARKET,BY SERVICE
6.1. Overview
6.2. Oligonucleotide Synthesis
6.3. Custom Oligonucleotide Synthesis
6.4. Pre-designed Oligonucleotide Synthesis
6.5. Gene Synthesis

7. DNA SYNTHESIS MARKET,BY APPLICATION
7.1. Overview
7.2. Research and Development
7.3. Therapeutics
7.4. Diagnostic

8. DNA SYNTHESIS MARKET,BY END-USER
8.1. Overview
8.2. Biopharmaceutical Companies
8.3. Academic and Research Institutes
8.4. Contract Research Organizations

9. DNA SYNTHESIS MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the DNA SYNTHESIS MARKET,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the DNA SYNTHESIS MARKET,
10.7. Key developments and Growth Strategies
10.7.1. New ProductLaunch/Service Deployment
10.7.2. Merger &Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income,2022
10.8.2. Major Players R&D Expenditure.2022

11. COMPANY PROFILES
11.1. LGC Biosearch Technologie
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Bioneer Corporation
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Thermo Fisher Scientific, Inc.
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. IBA GmbH
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Twist Bioscience
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Eton Bioscience
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Quintara Biosciences
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. EUROFINS SCIENTIFIC
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Integrated DNA Technologies, Inc
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. GenScript Biotech Corporation
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1 DNA SYNTHESIS MARKET, SYNOPSIS, 2018-2032
TABLE 2 DNA SYNTHESIS MARKET, ESTIMATES &FORECAST, 2018-2032(USD BILLION)
TABLE 3 DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 4 DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 DNA SYNTHESIS MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: DNA SYNTHESIS MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 9 US: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 10 US: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 US: DNA SYNTHESIS MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 12 CANADA: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 13 CANADA: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 14 CANADA: DNA SYNTHESIS MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 15 EUROPE: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 3 GERMANY: DNA SYNTHESIS MARKET,BY SERVICE,2018-2032 (USD BILLION)
TABLE 4 GERMANY: DNA SYNTHESIS MARKET,BY APPLICATION,2018-2032 (USD BILLION)
TABLE 5 GERMANY: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 6 FRANCE: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 7 FRANCE: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 8 FRANCE: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 9 ITALY: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 10 ITALY: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 ITALY: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 12 SPAIN: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 13 SPAIN: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 14 SPAIN: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 15 UK: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 16 UK: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 17 UK: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 18 REST OF EUROPE: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 21 ASIA-PACIFIC: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 24 JAPAN: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 25 JAPAN: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 26 JAPAN: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 27 CHINA: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 28 CHINA: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 29 CHINA: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 30 INDIA: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 31 INDIA: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 32 INDIA: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 33 AUSTRALIA: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 34 AUSTRALIA: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 AUSTRALIA: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 36 SOUTH KOREA: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 39 REST OF ASIA-PACIFIC: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 42 REST OF THE WORLD: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 45 MIDDLE EAST: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 48 AFRICA: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 49 AFRICA: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 50 AFRICA: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 51 LATIN AMERICA: DNA SYNTHESIS MARKET,BY SERVICE, 2018-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: DNA SYNTHESIS MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: DNA SYNTHESIS MARKET, BY END-USER, 2018-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE DNA SYNTHESIS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE DNA SYNTHESIS MARKET
FIGURE 4 DNA SYNTHESIS MARKET, SHARE (%), BY SERVICE, 2022
FIGURE 5 DNA SYNTHESIS MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 DNA SYNTHESIS MARKET, SHARE (%), BY END-USER, 2022
FIGURE 7 DNA SYNTHESIS MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: DNA SYNTHESIS MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: DNA SYNTHESIS MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: DNA SYNTHESIS MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: DNA SYNTHESIS MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 DNA SYNTHESIS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 LGC BIOSEARCH TECHNOLOGIE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 LGC BIOSEARCH TECHNOLOGIE: SWOT ANALYSIS
FIGURE 15 BIONEER CORPORATION:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 BIONEER CORPORATION:SWOT ANALYSIS
FIGURE 17 THERMO FISHER SCIENTIFIC, INC.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 THERMO FISHER SCIENTIFIC, INC.:SWOT ANALYSIS
FIGURE 19 IBA GMBH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 IBA GMBH:SWOT ANALYSIS
FIGURE 21 TWIST BIOSCIENCE.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 TWIST BIOSCIENCE.:SWOT ANALYSIS
FIGURE 23 ETON BIOSCIENCE:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 ETON BIOSCIENCE:SWOT ANALYSIS
FIGURE 25 QUINTARA BIOSCIENCES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 QUINTARA BIOSCIENCES: SWOT ANALYSIS
FIGURE 27 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 EUROFINS SCIENTIFIC: SWOT ANALYSIS
FIGURE 29 INTEGRATED DNA TECHNOLOGIES, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 INTEGRATED DNA TECHNOLOGIES, INC: SWOT ANALYSIS
FIGURE 31 GENSCRIPT BIOTECH CORPORATION:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 GENSCRIPT BIOTECH CORPORATION:SWOT ANALYSIS